What is the evaluation and management of elevated free testosterone in women?

Evaluation and Management of Elevated Free Testosterone in Women

Women with elevated free testosterone levels should undergo a comprehensive diagnostic workup to identify the underlying cause, with particular focus on ruling out androgen-secreting neoplasms, followed by appropriate targeted treatment based on etiology.

Diagnostic Evaluation

Initial Assessment

• Confirm the elevation with repeat testing using reliable methods:
  • Liquid chromatography-tandem mass spectrometry is preferred for total testosterone measurement 1
  • Calculate free testosterone from total testosterone and SHBG rather than using direct immunoassays, which are often inaccurate in women 2, 3

Laboratory Workup

1. Hormone Panel:

   • Total testosterone
   • Sex hormone-binding globulin (SHBG)
   • Free testosterone (calculated)
   • DHEAS (dehydroepiandrosterone sulfate)
   • LH and FSH
   • Estradiol
   • Thyroid function tests (to rule out thyroid disorders affecting SHBG)

2. Metabolic Assessment:

   • Fasting glucose
   • Lipid profile
   • Insulin levels (HOMA-IR)
   • HbA1c

Imaging Studies

• For markedly elevated testosterone levels (>8.7 nmol/L or >250 ng/dL):
  • Transvaginal ultrasound to evaluate ovarian morphology and detect ovarian masses
  • Adrenal CT scan if DHEAS is significantly elevated (>16.3 μmol/L or >6000 ng/mL) 4

Differential Diagnosis

Common Causes

1. Polycystic Ovary Syndrome (PCOS)

   • Most common cause (affects 2-10% of women) 4
   • Associated with insulin resistance, obesity, and metabolic disturbances
   • Characterized by oligo/anovulation and polycystic ovaries on ultrasound

2. Idiopathic Hirsutism

   • Increased sensitivity of hair follicles to normal androgen levels
   • Normal ovulatory function

3. Secondary Causes

   • Obesity (decreases SHBG, increasing free testosterone)
   • Insulin resistance
   • Medications (anabolic steroids, danazol, certain progestins)
   • Congenital adrenal hyperplasia (late-onset)

4. Androgen-Secreting Tumors

   • Rare but serious cause (approximately 0.2% of hyperandrogenic women) 4
   • Ovarian (e.g., hilar cell tumors, Sertoli-Leydig cell tumors)
   • Adrenal (e.g., adrenocortical carcinoma, adenoma)
   • Usually associated with rapidly progressive virilization

Management Approach

For Androgen-Secreting Neoplasms

• Surgical removal is the definitive treatment
• Refer to gynecologic oncology or endocrine surgery based on tumor origin

For PCOS and Other Non-Neoplastic Causes

1. Lifestyle Modifications

   • Regular exercise (150 minutes of moderate-intensity exercise weekly)
   • Mediterranean diet rich in fruits, vegetables, whole grains
   • Weight management (5-10% weight loss can significantly improve hormone levels) 5
   • Limited alcohol consumption

2. Pharmacological Management

   • Oral Contraceptives:

     • First-line therapy for women not seeking pregnancy
     • Increases SHBG, reducing free testosterone levels

   • Anti-androgens:

     • Spironolactone (50-200 mg daily)
     • Finasteride (2.5-5 mg daily)
     • Must be used with contraception due to teratogenic potential

   • Insulin Sensitizers:

     • Metformin (1500-2000 mg daily) for women with insulin resistance
     • Improves metabolic parameters and may help restore ovulation

   • Aromatase Inhibitors:

     • Letrozole can be considered in specific cases
     • Inhibits conversion of androgens to estrogens 6
     • Monitor for potential side effects including bone mineral density loss

3. For Women Desiring Fertility:

   • Ovulation induction with letrozole or clomiphene citrate
   • Avoid testosterone-suppressing medications if actively trying to conceive 5
   • Consider reproductive endocrinology referral if no response to first-line treatments

Monitoring

• Repeat hormone levels every 3-6 months initially, then annually once stabilized 5
• Regular assessment of clinical symptoms (hirsutism, acne, menstrual patterns)
• Monitor metabolic parameters annually (lipids, glucose, blood pressure)
• For women on anti-androgens, monitor electrolytes (especially with spironolactone)

Important Considerations

• Free testosterone and SHBG are more clinically relevant than total testosterone alone, as they reflect both ovarian and metabolic disturbances 1
• The positive predictive value of elevated total testosterone (>8.7 nmol/L) for neoplasm is only 9%, but the negative predictive value is 100% 4
• Calculated free testosterone has better diagnostic accuracy than direct immunoassay methods for detecting hyperandrogenism in women 2, 7
• Consider secondary causes of high SHBG including hyperthyroidism, liver disease/cirrhosis, advanced age, HIV infection, and malnutrition 5

By following this structured approach to evaluation and management, clinicians can effectively identify and treat the underlying cause of elevated free testosterone in women, improving both reproductive and metabolic outcomes.